Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
CLYM
FTH
Add up to 3 more stocks
CLYM
Climb Bio, Inc.
+0.63%
$11.12+0.07Delayed quote: Oct 6, 2026, 12:05 PM EDT
Market Cap
$636.74M
52W Range
$1.54 - $18.33
FTH
Faeth Therapeutics, Inc.
+5.55%
$28.61+1.50Delayed quote: Oct 6, 2026, 12:04 PM EDT
Market Cap
$737.40M
52W Range
$7.45 - $42.14
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | N/A |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 2.66 | 4.26 |
| P/S Ratio | N/A | N/A |
| P/FCF Ratio | N/A | N/A |
| EV/EBITDA | N/A | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 0.0% | 0.0% |
| Operating Margin | 0.0% | 0.0% |
| Net Margin | 0.0% | 0.0% |
| ROE | -24.1% | -113.0% |
| ROA | -23.4% | -103.3% |
| ROIC | -26.9% | -110.6% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 31.45 | 19.69 |
| Quick Ratio | 31.45 | 19.69 |
| Debt/Equity | 0.01 | 0.00 |
| Interest Coverage | N/A | -696.50 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.